Read + Share
Amedeo Smart
Independent Medical Education
Larkin HD. First Therapy Targeting ERBB2-Low Breast Cancer Approved. JAMA 2022;328:819.PMID: 36066537
Email
LinkedIn
Facebook
Twitter
Privacy Policy
